Form RW - Registration Withdrawal Request
19 Julho 2023 - 5:06PM
Edgar (US Regulatory)
ONCORUS, INC.
4 Corporate Drive
Andover, MA 01810
(339) 240-3330
July 19, 2023
VIA EDGAR
Securities and Exchange
Commission
Division of Corporation Finance
100 F. Street
N.E.
Washington, D.C. 20549
Re: |
Oncorus, Inc. Request for Withdrawal of Registration Statement on Form
S-3 (File No. 333-260718) |
Ladies and Gentlemen:
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the Securities Act), Oncorus, Inc. (the
Company) hereby requests that the Securities and Exchange Commission (the Commission) consent to the withdrawal of the Companys registration statement on Form
S-3 (File No. 333-260718), together with the exhibits thereto, which was filed on November 3, 2021 (the Registration Statement), as
of the date hereof or at the earliest practicable date hereafter. The Registration Statement was declared effective by the Commission on November 12, 2021, but no securities have been issued or sold under the Registration Statement.
Accordingly, the Company respectfully requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in connection
with the filing of the Registration Statement be credited to the Companys account to be offset against the filing fee for any future registration statement or registration statements.
If you have questions regarding this request, please contact the Companys legal counsel, Brian F. Leaf of Cooley LLP, at (703) 456-8053 or Courtney T. Thorne of Cooley LLP at (617) 937-2318.
|
Very truly yours, |
|
/s/ Alexander Nolte |
Interim Chief Financial Officer |
cc: |
Brian J. Shea (President and Interim Chief Executive Officer, Oncorus, Inc.) |
|
Brian F. Leaf (Cooley LLP) |
|
Courtney T. Thorne (Cooley LLP) |
Oncorus (CE) (USOTC:ONCR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Oncorus (CE) (USOTC:ONCR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Oncorus Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Oncorus Inc (PK)